Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
TG Therapeutics, Inc. (TGTX) had Free Cash Flow per Share of $-0.18 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$120.86M |
|
$5.06M |
|
$15.54M |
|
$105.31M |
|
$112.23M |
|
$8.62M |
|
$-3.15M |
|
$5.47M |
|
$5.47M |
|
$5.06M |
|
$5.06M |
|
$5.06M |
|
$5.06M |
|
$8.62M |
|
$7.65M |
|
146.68M |
|
162.77M |
|
$0.03 |
|
$0.03 |
|
| Balance Sheet Financials | |
$644.51M |
|
-- |
|
$12.18M |
|
$656.69M |
|
$160.21M |
|
$244.73M |
|
$259.19M |
|
$419.40M |
|
$237.29M |
|
$237.29M |
|
$237.29M |
|
158.17M |
|
| Cash Flow Statement Financials | |
$-28.71M |
|
$-12.93M |
|
$-6.10M |
|
$181.19M |
|
$133.44M |
|
$-47.75M |
|
$14.97M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.02 |
|
-- |
|
-- |
|
0.51 |
|
1.03 |
|
87.14% |
|
7.13% |
|
7.13% |
|
-- |
|
4.52% |
|
4.19% |
|
$-28.74M |
|
-- |
|
-- |
|
-- |
|
0.18 |
|
0.10 |
|
0.64 |
|
141.58 |
|
2.13% |
|
2.13% |
|
0.77% |
|
1.05% |
|
$1.50 |
|
|
Free Cash Flow per Share |
$-0.18 |
$-0.18 |
|